Log in to save to my catalogue

Correction: Patient eligibility for trials with imaging response assessment at the time of molecular...

Correction: Patient eligibility for trials with imaging response assessment at the time of molecular...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a22b6c35648c4250bc7b8c9caf5f9505

Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation

About this item

Full title

Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation

Publisher

England: BioMed Central Ltd

Journal title

Cancer imaging, 2024-07, Vol.24 (1), p.82-1, Article 82

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a22b6c35648c4250bc7b8c9caf5f9505

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a22b6c35648c4250bc7b8c9caf5f9505

Other Identifiers

ISSN

1470-7330,1740-5025

E-ISSN

1470-7330

DOI

10.1186/s40644-024-00724-5

How to access this item